Biofrontera (BFRI) Research & Development (2023 - 2026)
Biofrontera (BFRI) posted quarterly Research & Development of $787000.0 for Q4 2025, up 0.51% year-over-year from $783000.0 in Q4 2024, and down 7.85% quarter-over-quarter from $854000.0 in Q3 2025.
Biofrontera (BFRI) Research & Development (2023 - 2026) Analysis & Trends
Biofrontera's Research & Development history runs 3 years deep, the most recent figure standing at $787000.0 for Q4 2025.
- In Q4 2025, Research & Development rose 0.51% year-over-year to $787000.0; the TTM figure through Dec 2025 stood at $3.7 million (up 77.89% YoY), while the FY2025 annual figure was $3.7 million, up 78.03% from the prior year.
- Research & Development for Q4 2025 stood at $787000.0, down from $854000.0 in the prior quarter.
- The five-year high for Research & Development was $1.2 million in Q1 2025, with the low at $11000.0 in Q2 2023.
- The 3-year median for Research & Development is $669000.0 (2024), against an average of $535000.0.
- Peak annual rise in Research & Development reached 7000.0% in 2025, while the deepest fall reached 0.51% in 2025.
- Biofrontera's Research & Development stood at $33000.0 in 2023, then surged by 2272.73% to $783000.0 in 2024, then rose by 0.51% to $787000.0 in 2025.
- Business Quant data shows BFRI's Research & Development at $787000.0 in Q4 2025, $854000.0 in Q3 2025, and $870000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 448,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 448,000.00 |
| Dec 31, 2025 | 787,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Jun 30, 2025 | 870,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 783,000.00 |
| Sep 30, 2024 | 669,000.00 |
| Jun 30, 2024 | 621,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 11,000.00 |